About
Delve Bio offers a metagenomic next-generation sequencing diagnostic test, Delve Detect, that rapidly identifies a wide range of pathogens including bacteria, viruses, fungi, and parasites in cerebrospinal fluid to aid in the diagnosis of central nervous system infections such as meningitis and encephalitis.
Explore Delve Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.